ɔːlðˈoʊ ˈɛɡfɚ mjuːtˈeɪʃən ɪz nˌɑːt pɹˈɛzənt ɪn kɔːɹdˈoʊmə, ˈɛɡfɚɹ ɛkspɹˈɛʃən mˌaɪt pɹɪdˈɪkt ɹᵻspˈɑːns tʊ ˈɜːlətˌɪnɪb æz ʃˈoʊn ɪn ɹᵻpˈoːɹt baɪ dˈɑːktɚ sæmˈɪɹ ɹæstˈoʊɡi.
Although EGFR mutation is not present in chordoma, EGFR expression might predict response to erlotinib (as shown in report by Dr Sameer Rastogi).